ROSEN Law Firm Urges AdaptHealth Corp. Investors to Act Before Deadline in Class Action Lawsuit

On November 8, 2023, in New York City, the globally recognized investor rights law firm, ROSEN, issued an advisory reminder to AdaptHealth Corp. AHCO shareholders regarding the impending lead plaintiff deadline. The deadline, set for December 26, 2023, is critical for investors who acquired shares within the specified Class Period or through the company’s secondary public offering (SPO) to potentially secure restitution without incurring out-of-pocket fees, under a contingency fee arrangement.

Understanding the Class Action Against AHCO

Investors who purchased AHCO common stock between August 4, 2020, and February 27, 2023, or through the SPO on or around January 5, 2021, are invited to partake in the class-action lawsuit. The litigation alleges that AdaptHealth Corp., headquartered in Plymouth Meeting, Pennsylvania, misrepresented its ability to foster organic growth in its diabetes segment, engaged in inappropriate billing practices, and provided misleading statements about the company’s operations and prospects. Moreover, the lawsuit contents that the SPO contained materially untrue statements, omissions, and lacked required disclosures, leading to harm to investors when the truth surfaced.

ROSEN’s Advocacy for Investor Rights

With its global focus on representing investors in securities class actions and shareholder derivative litigation, ROSEN Law Firm stands out for its proven track record of successful leadership roles in similar lawsuits. The firm has shown a commitment to attaining substantial recoveries for investors, highlighted by significant settlements, including the largest against a Chinese company. The law group’s attorneys, including founding partner Laurence Rosen, have garnered recognition for their legal prowess in this domain.

What Investors Should Do

Investors in AHCO who wish to participate in the class action should reach out to ROSEN Law Firm for guidance. With the December deadline approaching, it is crucial for those who want to act as lead plaintiff to contact the firm. The lead plaintiff will represent other class members in the lawsuit. Investors who prefer not to take an active role still have the option to remain absent class members and await the outcome.

Parallel Case in the Investment World: META

While AdaptHealth navigates this class-action lawsuit, it's worth noting that other companies, such as Meta Platforms, Inc. META, based in Menlo Park, California, are also publicly traded entities where shareholder vigilance regarding company disclosures and practices is crucial. While no class-action is highlighted against META in this context, as with any investment, shareholders are encouraged to stay informed and exercise their rights diligently.

Conclusion

With the clock ticking toward the late December deadline, ROSEN Law Firm advocates for AdaptHealth shareholders to reflect on their options and act timely should they wish to participate in the lawsuit. Owing to their extensive experience and litigative success, ROSEN continues to serve as a staunch defender of investor rights in the complex landscape of securities class actions.

Investment, AdaptHealth, ClassAction